Longer delay of RRT does no good for critically ill severe AKI patients: Study
France: Longer postponement of renal replacement therapy (RRT) did not confer any additional benefit and is indeed harmful in critically ill patients with severe acute kidney injury (AKI) and no severe complication, finds a recent study in the journal Lancet.
Delaying RRT for some time in critically ill patients with severe AKI and no severe complication is safe and allows optimization of the medical devices use. However, there remains uncertainty on the duration for which RRT can be postponed without risk. Prof Stéphane Gaudry, Département de réanimation médico-chirurgicale, APHP Hôpital Avicenne, Bobigny, France, and colleagues aimed to test the hypothesis that a more-delayed initiation strategy would result in more RRT-free days, compared with a delayed strategy.
For this purpose, the researchers performed an unmasked, multicentre, prospective, open-label, randomised, controlled trial in 39 intensive care units in France. Critically ill patients with severe AKI (defined as Kidney Disease: Improving Global Outcomes stage 3) were monitored until they had oliguria for more than 72 h or a blood urea nitrogen concentration higher than 112 mg/dL.
Patients were randomly assigned in the ratio 1:1 to receive either a strategy (delayed strategy) in which RRT was started just after randomization or to a more-delayed strategy. With the more-delayed strategy, RRT initiation was postponed until mandatory indication (noticeable hyperkalaemia or metabolic acidosis or pulmonary oedema) or until blood urea nitrogen concentration reached 140 mg/dL.
The primary outcome was the number of days alive and free of RRT between randomization and day 28 and was done in the intention-to-treat population.
5336 patients were assessed between May 7, 2018, and Oct 11, 2019, out of which 278 patients underwent randomization; 137 were assigned to the delayed strategy and 141 to the more-delayed strategy.
Key findings of the study include:
- The number of complications potentially related to acute kidney injury or to RRT were similar between groups.
- The median number of RRT-free days was 12 days (IQR 0–25) in the delayed strategy and 10 days (IQR 0–24) in the more-delayed strategy.
- In a multivariable analysis, the hazard ratio for death at 60 days was 1·65 with the more-delayed versus the delayed strategy.
- The number of complications potentially related to acute kidney injury or renal replacement therapy did not differ between groups.
"In severe acute kidney injury patients with oliguria for more than 72 h or blood urea nitrogen concentration higher than 112 mg/dL and no severe complication that would mandate immediate RRT, longer postponing of RRT initiation did not confer an additional benefit and was associated with potential harm," wrote the authors.
Reference:
The study titled, "Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial," is published in the journal Lancet.
DOI:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00350-0/fulltext
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.